Our Location

India, USA

ABOUT US

CIBUS Biotechnologies

CIBUS Biotechnologies, a MSME Startup with a team of specialists having more than one million manhours of expertise in aquaculture. Having studied the growth of aquaculture in Asian countries with respect to conventional farming and poor productivity due to non-implementation of proven technologies, CIBUS was formed to take up this challenge in Indian Aquaculture industry and after a thorough study of Indian conditions for the past two years, have developed the following three technologies for which the application for patent is under submission.

  • Hybrid RAS Indoor – for large scale farmers / entrepreneurs
  • Hybrid RAS Outdoor – for medium scale farmers / entrepreneurs
  • In Pond Raceway Systems – for small scale farmers / entrepreneurs
Benefits of Tilapia Fish & Shrimps

World Aquaculture Market

The global market for aquaculture estimated at US$191.3 billion in the year 2022, is projected to reach a size of US$ 232.4 billion by 2026.

Shrimp :

Global farmed shrimp production is currently 5.2mmt, with a total industry value of $60 billion on the retail side. This is expected to nearly double by 2033, with production to reach 9 MMT at an industry value of $125 billion.

Shrimp is India’s highest valued aquaculture export at $6.28 billion in 2022 (from 0.94 MMT production), with nearly 76% of all farming done in Andhra Pradesh and over 40% of the market dedicated to the United States (i.e., near 400,000 MTY).

India’s Potential in World Shrimp Market :

India can easily achieve a growth from the current levels to a minimum of 2.5MMT to a maximum of 3 MMT by 2033

Tilapia :

The global Tilapia market currently enjoys a value of. US$ 14.1 billion and is forecasted to reach a size of US$ 22.3 billion by the end of 2033.Currently there is limited export of Tilapia from India and to this end India has set a transformation and ambitious goal to produce 0.766 MMT by 2026-27 and 2.155 MMT, valued at US$ 4.398 billion by 2032.

Mains Concerns in Indian Aquaculture :

The main issues are diseases, environmental pollution, water quality and quantity that's restraining the profitability of farming in India. Our proposed Hybrid RAS will be the solution to make India the No. 1 player in the world in shrimp and tilapia production. To further this, we are also working to develop blockchain digital tracing of product within the value chain to aid rapid communication and transparency to reduce the impact of consignment rejections, which cause a $1 billion annual loss in Indian shrimp exports.

Recent Challenges

India Ranks Number 2 on shrimp production. Traditional methods of shrimp farming in India are able to produce just between 3 MT per acre while our Hybrid RAS will produce upto 60 MT per acre.

Disease

WSSV, EHP, EMS, White feces
  • Increased densities
  • Increased use of antibiotics
  • Lack of biosecurity
  • Poor management practices

Economics

Reduced margins
  • Increased material, seed, and feed costs
  • Up to 25 – 40% losses due to disease

Environmental

Reduced Water quality & quantity
  • Rising pollution due to human activities
  • Rising population competing for water resources
  • Increasing demand for terrestrial food production

Recirculating Aquaculture Systems

Reasons for RAS

There is deficit of proper knowledge, expertise in technical management of Recirculatory systems and entrepreneurial attitude for commercial scale units. The high investment costs may have kept RAS away from our country until now. But there is an amazing potential for it in India and with growing interest, in the next 5 years, RAS would be the next revolution in Inland Aquaculture sector and these are going to be seen in many places in India for sure in coming years.

Simplified illustration of RAS technology

High Output Of Shrimp Ranging From 30 Tons To 60 Tons/Acre

Our Proposed Roadmap for Shrimp Industry

Promises

15x’s

Increase in produce

4%

Water consumption

100%

Of quality and produce

7%

Annual growth